On September 29 and 30, 2022 the North American femtech community is coming together again in Boston for the 4th edition of Women’s Health Innovation Summit. Each year the 2-day event invites selected startups to pitch their solutions in front of industry leaders and investors. Just recently the finalists, who were selected by 10 leading VCs in the space, were announced.
Selection committee members included Lindsay Taylor Wood (The Helm), Maria Velissaris (SteelSky Ventures), Alyssa Jaffee (7Wire Ventures), Jenny Yip (Adjuvent Capital), Annie Theriault (Cross Border Impact Ventures), Tracy Warren (Astarte Medical), Margaret Malone (Flare Capital), Linda Greub (Avestria Capital), Anula Jayasuriya (EXXclaim Capital), and Elizabeth Bailey (Rhia Ventures).
Women’s Health Innovation Summit: Pitch Competition Finalists
This year there’s 24 of them and we’re excited to share more about the startups and scale-ups who made the cut this year.
3 Daughters is a clinical development company focused on Evolutionary Healthcare for Women. Their first solution is a frameless, magnetic, non-hormonal intrauterine device (IUD) based on physics and geometry for long-acting contraception.
Ananya Health is building a medical device to freeze abnormal cells before they become cervical cancer. Their proprietary cryoablation platform removes the reliance on consumable gar, making the procedere portable, battery-powered, and 10x cheaper than traditional cryo.
Antiva Biosciences is a clinical-stage, global women’s health company developing novel, topical therapeutics for the treatment of cancerous lesions caused by HPV infection.
AOA Dx has partnered with a leading researcher at McGill University to develop the first early stage ovarian cancer liquid biopsy diagnostic test.
Endometrics developed a unique solution for non-invasive diagnosis of endometriosis using menstrual blood and endometrial cells in it.
Escala is on a mission to introduce a life changing repair solution for women with pelvic organ prolapse (POP). They developed Apyx, the first minimally invasive, incision-free device that replaces surgery.
Evvy is on a mission to close the gender health gap by discovering and leveraging overlooked biomarkers in the female body – starting with the vaginal microbiome.
Hera‘s vision is to become an industry leader in tissue-based diagnostics for women’s health, specifically in diagnostic assays for non-malignant and non-infectious disorders of the female reproductive tract.
iSONO Health has developed an AI-driven ultrasound platform for health monitoring. Their first FDA-cleared and patented solution, ATUSA, is the world’s first automated and wearable ultrasound with an ML engine to transform breast health management for millions of women every year.
Khyria is a digital health solution for women in midlife and menopause that addresses the most pressing symptoms and long-term health priorities.
Materna Medical is a novel OBGYN platform company dedicated to protecting and restoring women’s pelvic health. The medical device company is focused on preventing and treating some of the most common pelvic conditions women face.
MiMARK is focused on improving gynecological diagnostics based on building a ‘new’ liquid biopsy: the gynecologic fluid. The company’s mission is to improve women’s health by developing innovative and minimally invasive diagnostic assays to solve unmet clinical gynecological needs.
MirZyme is a biotech company that has a potential cure for preeclampsia, a life-threatening maternal hypertensive disorder of pregnancy.
Motivity Care works with clients at every stage of aging providing a unique point of contact concierge/chief of staff approach and a best-in-class technology that keeps vital medical, legal and personal information secure and accessible 24/7.
Origin is a leading provider of pelvic floor and whole-body physical therapy with a specialized focus on pregnancy, postpartum, menopause, and sexual health.
Raydiant Oximetry is on a mission to develop a better fetal monitor.
SLBST Pharma seeks to address the pain of endometriosis by repurposing a 60-year-old drug as a first non-hormonal long-term treatment. The company holds issued US and European patents for the use of hydroxychloroquine (HCQ) to treat endometriosis.
TheraB Medical is a medical device company commercializing its first product, the SnugLit Portable Phototherapy System, the only portable and wearable phototherapy garment that allows maternal-infant bonding and breastfeeding without interrupting jaundice treatment.
UE LifeSciences was founded to lead the effort in bringing early detection of breast cancer to geographies where the incidence is rising and the Western model of screening is unadaptable.
Ultrasound AI has developed a platform that merges the power of artificial intelligence with existing ultrasound technology to improve clinical judgment and outcomes for mothers and their babies.
Vital Startup Health
Vital Startup Health has developed the first maternal mental health platform using Virtual Reality for personalized, equitable and clinically guided care.
Woost is dedicated to the development of novel technologies to significantly improve the awareness and diagnosis of gynecological health conditions starting with polycystic ovary syndrome (PCOS).
Work & Mother
Proptech meets femtech. Work & Mother is a commercial building lactation suite amenity